What was recalled
This page synthesizes the regulatory and consumer-facing trajectory of ethoxyquin in pet food. Ethoxyquin was developed by Monsanto in the 1950s and approved for use in animal feed as a fat preservative due to its high efficacy at preventing oxidation of polyunsaturated fatty acids. The compound is particularly effective in fish meal preservation where the high omega-3 fatty acid content creates rapid oxidation risk during storage and transport. Pet food manufacturers adopted ethoxyquin widely in the 1970s and 1980s for similar fat-stability purposes in finished kibble.
The 1988 FDA investigation followed consumer reports of liver enzyme elevation, immune dysfunction, skin allergies, and reproductive issues in dogs eating ethoxyquin-preserved pet food. The FDA reviewed the available toxicology data and requested industry reduction of ethoxyquin use levels in pet food. The current FDA regulatory limits are 75 ppm in finished pet food (40 CFR 573.380) and 100 ppm in fish meal as an ingredient. European Union regulation has been more restrictive — the European Commission Implementing Regulation 2017/962 suspended ethoxyquin authorization in EU animal feed pending additional safety data; the suspension remains in effect. Tocopherol-based preservation (mixed natural vitamin E + rosemary extract + green tea extract) became the premium pet food industry alternative through the 1990s-2000s and is now the dominant preservation system in premium and mid-tier formulations.
Why it was recalled
The structural controversy is whether the current 75 ppm regulatory limit provides adequate safety margin for long-term feeding of pet food containing ethoxyquin, and whether the residual ethoxyquin from fish meal ingredients (which can enter finished food below disclosure thresholds) presents additional exposure concerns. The toxicology data available at the 1988 investigation included rodent and dog feeding studies showing liver enzyme changes at higher doses (5,000-12,500 ppm) and limited evidence at the FDA-permitted use levels. The data gap drives the persistent consumer-facing concern: ethoxyquin has documented adverse effects at substantially elevated doses, but the long-term feeding effects at 75 ppm and below have not been comprehensively characterized in modern toxicology study formats.
The fish meal ingredient disclosure issue is structural. Fish meal is widely used in pet food for protein and omega-3 fatty acid content. Suppliers typically pre-preserve fish meal with ethoxyquin (up to 100 ppm) during processing and transport. The pet food manufacturer purchasing the fish meal may not be the entity adding ethoxyquin to its formulation, leading to labeling complexity. Some premium brands now specifically request ethoxyquin-free fish meal (preserved with tocopherol mixed natural vitamin E instead) from their suppliers, but the supply chain disclosure varies. Pet food brand marketing claiming "no added preservatives" may still contain ethoxyquin from pre-preserved fish meal ingredients unless the brand specifies the fish meal sourcing protocol. The FDA pet food information documents the regulatory framework.
Health risks for your pet
The documented adverse-event evidence for ethoxyquin includes: (1) liver enzyme elevation at elevated doses in rodent and dog feeding studies; (2) consumer-reported clinical observations of liver disease, skin allergies, immune dysfunction, and reproductive issues in dogs eating ethoxyquin-preserved pet food (driving the 1988 FDA investigation); (3) mutagenicity and clastogenicity findings in some in-vitro assays; (4) chronic exposure data gaps at the current regulatory use levels for long-term feeding. The current 75 ppm regulatory limit is supported by available toxicology data but the data set is older and does not include modern toxicology study protocols. For consumers prioritizing precautionary positioning, ethoxyquin-free formulations (preserved with mixed tocopherols + rosemary extract + green tea extract) provide the alternative.
What to do if you bought affected product
Pet owners can manage ethoxyquin exposure through: (1) ingredient deck inspection — ethoxyquin appears in the ingredient list when added directly to the pet food (typically near the end of the ingredient deck with other preservatives); brands using natural preservation will list mixed tocopherols, rosemary extract, green tea extract, or citric acid instead; (2) fish meal disclosure — brands publishing fish meal sourcing protocols (ethoxyquin-free preservation, tocopherol pre-preservation) provide higher transparency than brands not disclosing fish meal preservation method; (3) premium brand selection — most premium and mid-tier brands have transitioned to tocopherol-based preservation; ethoxyquin persists primarily in value-tier dry pet food; (4) EU-compliant brand consideration — brands compliant with the European Commission Implementing Regulation 2017/962 suspension are by definition ethoxyquin-free. The menadione synthetic vitamin K controversy covers a related synthetic-supplement framework debate.
How this affects KibbleIQ’s grade
The KibbleIQ rubric v15 weights tocopherol-based preservation favorably over ethoxyquin-based preservation per our published methodology. Formulations using mixed tocopherols, rosemary extract, green tea extract, or citric acid receive scoring advantage over formulations using ethoxyquin. The rubric also considers fish meal sourcing transparency where brands publishing fish meal preservation protocols (ethoxyquin-free preservation) receive transparency scoring advantage. The persistent regulatory data gap around long-term ethoxyquin exposure at the current 75 ppm limit drives the rubric’s precautionary positioning toward natural antioxidant preservation systems.